Statistics for Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes
Total visits
views | |
---|---|
Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes | 78 |
Total visits per month
views | |
---|---|
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
July 2025 | 0 |
File Visits
views | |
---|---|
nihms-1689946.pdf | 125 |
java.util.UUID:9911af93-f721-4c68-9ef1-b27e8a968d1b | 65 |
java.util.UUID:91c615ba-7c87-4a0f-ac40-0a0db94199c6 | 10 |
java.util.UUID:b3d8b8e6-25f4-45ab-9ec9-b4bf930f2d67 | 5 |
Top country views
views | |
---|---|
United States | 63 |
Bulgaria | 4 |
Algeria | 1 |
Israel | 1 |
Malaysia | 1 |
Thailand | 1 |
Top city views
views | |
---|---|
Wilmington | 44 |
Fairfield | 6 |
Sofia | 4 |
Ann Arbor | 2 |
Cambridge | 2 |
Houston | 2 |
Algiers | 1 |
Andover | 1 |
Falls Church | 1 |
Haifa | 1 |
San Francisco | 1 |
Seremban | 1 |
Washington | 1 |